Deterioration of Intended Target Volume Radiation Dose Due to Anatomical Changes in Patients with Head-and-Neck Cancer

Simple Summary Delivered radiation dose in the patient during a course of 6–7 weeks of treatment can differ from intended radiation dose in the treatment planning. This study analyzes these dose differences in the target volumes in a set of 188 head-and-neck cancer patients. It was found that large dose deteriorations in targets occur in a minority of patients, although more frequently when smaller margins were used. The correlation to visual estimation of differences based on changing anatomy was poor. Therefore, dosimetric selection tools during treatment to assess differences seem warranted to identify patients at risk for under or overdosage. With such tools, patients at risk can be selected to adjust the treatment plan during treatment (adaptive radiotherapy) to correct the radiation dose. Abstract Delivered radiation dose can differ from intended dose. This study quantifies dose deterioration in targets, identifies predictive factors, and compares dosimetric to clinical patient selection for adaptive radiotherapy in head-and-neck cancer patients. One hundred and eighty-eight consecutive head-and-neck cancer patients treated up to 70 Gy were analyzed. Daily delivered dose was calculated, accumulated, and compared to the planned dose. Cutoff values (1 Gy/2 Gy) were used to assess plan deterioration in the highest/lowest dose percentile (D1/D99). Differences in clinical factors between patients with/without dosimetric deterioration were statistically tested. Dosimetric deterioration was evaluated in clinically selected patients for adaptive radiotherapy with CBCT. Respectively, 16% and 4% of patients had deterioration over 1 Gy in D99 and D1 in any of the targets, this was 5% (D99) and 2% (D1) over 2 Gy. Factors associated with deterioration of D99 were higher baseline weight/BMI, weight gain early in treatment, and smaller PTV margins. The sensitivity of visual patient selection with CBCT was 22% for detection of dosimetric changes over 1 Gy. Large dose deteriorations in targets occur in a minority of patients. Clinical prediction based on patient characteristics or CBCT is challenging and dosimetric selection tools seem warranted to identify patients in need for ART, especially in treatment with small PTV margins.

[1]  Xiao Han,et al.  The evaluation of a hybrid biomechanical deformable registration method on a multistage physical phantom with reproducible deformation , 2018, Radiation Oncology.

[2]  J. Battista,et al.  Online daily assessment of dose change in head and neck radiotherapy without dose‐recalculation , 2018, Journal of applied clinical medical physics.

[3]  J. Thariat,et al.  Adaptive radiotherapy in head and neck cancer is required to avoid tumor underdose , 2018, Acta oncologica.

[4]  Eric Zapletal,et al.  Labeling for Big Data in radiation oncology: The Radiation Oncology Structures ontology , 2018, PloS one.

[5]  T. Vercauteren,et al.  Late mucosal ulcers in dose-escalated adaptive dose-painting treatments for head-and-neck cancer , 2017, Acta oncologica.

[6]  I. Chetty,et al.  Caution Must Be Exercised When Performing Deformable Dose Accumulation for Tumors Undergoing Mass Changes During Fractionated Radiation Therapy. , 2016, International journal of radiation oncology, biology, physics.

[7]  Tejinder Kataria,et al.  Clinical outcomes of adaptive radiotherapy in head and neck cancers. , 2016, The British journal of radiology.

[8]  Kerrie Mengersen,et al.  Predicting the need for adaptive radiotherapy in head and neck cancer. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  Jan-Jakob Sonke,et al.  Deformable image registration for adaptive radiation therapy of head and neck cancer: accuracy and precision in the presence of tumor changes. , 2014, International journal of radiation oncology, biology, physics.

[10]  James A Purdy,et al.  Clinical outcomes among patients with head and neck cancer treated by intensity‐modulated radiotherapy with and without adaptive replanning , 2014, Head & neck.

[11]  Jianji Pan,et al.  Will weight loss cause significant dosimetric changes of target volumes and organs at risk in nasopharyngeal carcinoma treated with intensity-modulated radiation therapy? , 2014, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

[12]  C. Yip,et al.  Co-registration of cone beam CT and planning CT in head and neck IMRT dose estimation: a feasible adaptive radiotherapy strategy. , 2014, The British journal of radiology.

[13]  M. V. van Herk,et al.  Adaptive radiotherapy with an average anatomy model: evaluation and quantification of residual deformations in head and neck cancer patients. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  Johannes A Langendijk,et al.  Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[15]  Wei Wang,et al.  Replanning during intensity modulated radiation therapy improved quality of life in patients with nasopharyngeal carcinoma. , 2013, International journal of radiation oncology, biology, physics.

[16]  Lei Dong,et al.  Adaptive radiotherapy for head and neck cancer--dosimetric results from a prospective clinical trial. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  J. Dai,et al.  Dosimetric variations of target volumes and organs at risk in nasopharyngeal carcinoma intensity-modulated radiotherapy. , 2012, The British journal of radiology.

[18]  Robert Jeraj,et al.  Radiotherapy for head and neck tumours in 2012 and beyond: conformal, tailored, and adaptive? , 2012, The Lancet. Oncology.

[19]  Lei Dong,et al.  Adaptive radiotherapy for head-and-neck cancer: initial clinical outcomes from a prospective trial. , 2012, International journal of radiation oncology, biology, physics.

[20]  S Marzi,et al.  Anatomical and dose changes of gross tumour volume and parotid glands for head and neck cancer patients during intensity-modulated radiotherapy: effect on the probability of xerostomia incidence. , 2012, Clinical oncology (Royal College of Radiologists (Great Britain)).

[21]  Linda Hong,et al.  Adaptive planning in intensity-modulated radiation therapy for head and neck cancers: single-institution experience and clinical implications. , 2011, International journal of radiation oncology, biology, physics.

[22]  V. Khoo,et al.  The dosimetric consequences of anatomic changes in head and neck radiotherapy patients , 2010, Journal of medical imaging and radiation oncology.

[23]  J. Mandrekar.  Receiver operating characteristic curve in diagnostic test assessment. , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[24]  Kevin J Harrington,et al.  Weekly volume and dosimetric changes during chemoradiotherapy with intensity-modulated radiation therapy for head and neck cancer: a prospective observational study. , 2010, International journal of radiation oncology, biology, physics.

[25]  Jan-Jakob Sonke,et al.  First clinical experience with a multiple region of interest registration and correction method in radiotherapy of head-and-neck cancer patients. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[26]  Qiuwen Wu,et al.  Adaptive replanning strategies accounting for shrinkage in head and neck IMRT. , 2009, International journal of radiation oncology, biology, physics.

[27]  Ping Xia,et al.  Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer. , 2006, International journal of radiation oncology, biology, physics.

[28]  Daniel Rueckert,et al.  Nonrigid registration using free-form deformations: application to breast MR images , 1999, IEEE Transactions on Medical Imaging.